Reacting to epidemic and emerging infectious diseases: QIAGEN's diagnostic and surveillance response to MPXV
14 Oct 2022

MonkeyPox is a zoonotic disease that can be fatal. The disease is considered endemic in west and central Africa, but cases are infrequent. There has been a recent public health concern as MonkeyPox cases have seen a resurgence in non-endemic countries across the globe, including in Europe, North America, and Australia.

This webinar will provide an epidemiological and clinical overview of the current MonkeyPox outbreak in non-endemic regions. Diagnostic challenges and QIAGEN’s RUO solutions will also be discussed.

Key learning objectives

  • Update on MonkeyPox epidemiology and disease overview
  • Diagnostic challenges of MonkeyPox
  • QIAGEN’s molecular solutions for research and surveillance

Who should attend?

  • Clinical virologists
  • Medical technologists
  • Infectious disease physicians
  • Public and Global health specialists

Certificate of attendance

All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

QIAGEN